Yarwood Jeremy sold $115K of NEOG
Yarwood Jeremy (Chief Scientific Officer) sold 9,051 shares of NEOGEN CORP (NEOG) at $12.67 ($0.11M total) on 2026-11-04.
How this was made
The 30-second read
Why it matters
The complete divestiture by a senior officer may be interpreted as a negative signal, but the modest size limits market reaction.
Market read
A small insider sell with no immediate price target; likely limited trading relevance.
What to watch
No other material news accompanies the filing; the market may already price insider activity.
Background
SEC Form 4 filing discloses insider transactions. Such filings are primary sources for insider activity.
Ticker impact
Chief Scientific Officer Yarwood Jeremy sold 9,051 shares for $114,676, leaving zero holdings.
likely slight downward pressure as investors price the insider sell
The sale is small but represents a C-suite insider exiting completely, which can be viewed negatively by the market.
Market effects
Minimal impact on the broader biotech sector; the sale is company‑specific.
No regional effect.
Limited to investors tracking NEOG.
Counterpoint
The sale could be a routine liquidity event unrelated to company fundamentals.
Key entities
- OfficerYarwood Jeremy
Chief Scientific Officer of NEOGEN Corp.



